Norgine Competitors and Similar CompaniesClear all
Norgine's competitors and similar companies include Celcuity, C2i Genomics and Kura Oncology.
 Celcuity Celcuity is a clinical-stage biotechnology company developing integrated companion diagnostic and therapeutic strategies using its proprietary functional cellular analysis platform. |  C2i Genomics C2i Genomics is a company that provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations. |  Kura Oncology Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers. | ||
Founding Date | Founding Date 1906 | Founding Date 2012 | Founding Date 2019 | Founding Date 2007 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Amsterdam, NL HQ Frenchs Forest, AU Leuven, BE Herlev, DK København, DK Dreux, FR Rueil Malmaison, FR see more | Locations Minneapolis, US HQ | Locations New York, US HQ Tirat Carmel, IL | Locations San Diego, US HQ Boston, US San Diego, US San Diego, US |
Employees | Employees 1,050 | Employees 3011% increase | Employees 22 | Employees 5712% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 589.2 m | Valuation ($) N/A | Valuation ($) 1.3 b |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 14.5m | Total funding raised $ 112m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Celcuity
HQ
Minneapolis, US
Employees
30↑ 11% increase
Celcuity is a clinical-stage biotechnology company developing integrated companion diagnostic and therapeutic strategies using its proprietary functional cellular analysis platform.
View companyC2i Genomics
HQ
New York, US
Employees
22
C2i Genomics is a company that provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.
View companyKura Oncology
HQ
San Diego, US
Employees
57↑ 12% increase
Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
View company